Daily, low-dose aspirin may be an effective treatment for a common type of liver disease, according to a new study.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by fat buildup in the liver, affecting its function. Also called non-alcoholic fatty liver disease, it is commonly associated with factors such as type 2 diabetes and obesity, but is not related to alcohol consumption.
Up to a third of Americans have fat build up in the liver and in about 2-5% that…
Continue Reading
News Source: www.forbes.com